Background illustration for clinical trials search

Paid Clinical Trials Pasadena

Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Los Angeles CA, Orange CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Los Angeles CA, La Jolla CA, Gilbert AZ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: Los Angeles CA, Orange CA, Irvine CA, Sacramento CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase 3, Recruiting

MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial

for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Male

Age: 20+

Code: NCT07162194

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Los Angeles CA, Santa Monica CA, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

for
Sarcoma,Soft Tissue
Location: Los Angeles CA, Santa Monica CA, Omaha NE,
Sponsor: Intensity Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06263231

Phase 3, Recruiting

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

for
Recurrent Plasmablastic Lymphoma,
Location: Los Angeles CA, Duarte CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07332507

Phase 1, Recruiting

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

for
Renal Cell Carcinoma
Location: Los Angeles CA, Fullerton CA, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227402

Phase 3, Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Los Angeles CA, Salt Lake City UT, Portland OR,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase 2, Recruiting

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT05989828

Phase 1, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

for
Gastrointestinal Cancers
Location: Los Angeles CA, Santa Monica CA, Aurora CO,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07539311

Phase 2, Recruiting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Los Angeles CA, Salt Lake City UT, Portland OR,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07406633

Phase 2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Los Angeles CA, Duarte CA, La Jolla CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase 1, Phase 2, Recruiting

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

for
Malignant Testicular Germ Cell Tumor
Location: Los Angeles CA, Loma Linda CA, Birmingham AL,
Sponsor: University of Southern California

Sex: Male

Age: 18+

Code: NCT06060873

Recruiting

Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study

for
Lung Non-Small Cell Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT07339254

Recruiting

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT07306338

Recruiting

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Los Angeles CA, Birmingham AL, Durham NC, New York NY,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07246863

Phase 2, Recruiting

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Los Angeles CA, Birmingham AL, Tampa FL, Charleston SC,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07098988

Phase 2, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Los Angeles CA, Duarte CA, Irvine CA, San Francisco CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase 3, Recruiting

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

for
Sinonasal Squamous Cell Carcinoma,
Location: Los Angeles CA, Orange CA, Irvine CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07281417

Phase 2, Recruiting